<DOC>
	<DOC>NCT00043771</DOC>
	<brief_summary>Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.</brief_summary>
	<brief_title>Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>History of CHF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>CHF</keyword>
</DOC>